Market Overview

UPDATE: J.P. Morgan Lowering Price Target on Compass Minerals International

Share:

J.P. Morgan Chase & Co. is out with a research report on Compass Minerals International (NYSE: CMP) and is lowering its price target to $81 from $83, but is keeping its Neutral rating on shares.

In a note to clients, J.P. Morgan Chase & Co. writes, "Compass Minerals is contending with the elements: the Salt and Specialty Fertilizer segments were afflicted with weather events in the same year. A tornado interrupted Salt production at the Goderich mine. Wet weather conditions at the Great Salt Lake led to a reduced SOP harvest, which resulted in lower production volumes and higher production costs. We reduced our Q4:11 EPS forecast from $2.15 to $1.96. We lowered our 2012 EPS projection from $6.00 to $5.10. We reduced our 2013 EPS estimate from $7.20 to $6.10. We rate Compass shares Neutral. Our December 2012 price target is $81.00, or 9.5x EBITDA and 15.8x EPS for 2012E."

Shares of CMP closed at $80.50 yesterday.

Posted-In: J.P. Morgan Chase & Co.Analyst Color Price Target Analyst Ratings

 

Related Articles (CMP)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TOLGoldman SachsInitiates Coverage On42.0
KBHGoldman SachsInitiates Coverage On36.0
YEXTSunTrust Robinson HumphreyMaintains28.0
LHCGSunTrust Robinson HumphreyMaintains160.0
DLRSunTrust Robinson HumphreyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Bank of America Lowers PO on KEMET to $13, Maintains Buy

UPDATE: Bank of America Raises PT to $30 on Theravance